tissue inhibitor of metalloproteinase 3
| GO Term | Evidence Code | PMID |
|---|---|---|
| response to hormone | ||
| negative regulation of peptidase activity |
|
|
| response to cytokine | ||
| negative regulation of proteolysis | ||
| negative regulation of membrane protein ectodomain proteolysis |
| GO Term | Evidence Code | PMID |
|---|---|---|
| basement membrane | ||
| extracellular space | ||
| extracellular space | ||
| extracellular matrix |
| GO Term | Evidence Code | PMID |
|---|---|---|
| metalloendopeptidase inhibitor activity | ||
| metalloendopeptidase inhibitor activity | ||
| zinc ion binding | ||
| metal ion binding |
|
| InterPro |
|---|
| Netrin domain |
| Protease inhibitor I35 (TIMP) |
| Proteinase inhibitor I35b (TIMP), C-terminal |
| Tissue inhibitor of metalloproteinases-like, OB-fold |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:0090114 | Sorsby's fundus dystrophy | |
| DOID:12930 | dilated cardiomyopathy |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026